Top Links (last 48h)



Links last updated:
Next Page >
 
Page 1

Filter Links & Tweets:


Jan 13 • Virological | 12 expert tweets ->
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 Áine O’Toole, MSc1,$,*, Verity Hill, MSc1*, Oliver G. Pybus, DPhil2, Alexander Watts, PhD3,4, Isaac I. Bogoch, MD5,6, Kamran Khan MD, MPH3,4,5, Jane P. Messina, PhD7, The COVID-19 Genomics UK (COG-UK) consortium8, Network for Genomic Surveillance in South...

What Does a More Contagious Virus Mean for Schools?
The coronavirus variant discovered in Britain is more easily spread among children, as it is among adults. Current safeguards should protect schools, experts said, but only if strictly enforced.

Jan 13 • Journal of Hospital Infection | 11 expert tweets ->
Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus (SARS-CoV-2)
The Covid-19 pandemic has caused untold disruption and enhanced mortality rates around the world. Understanding the mechanisms for transmission of SARS-CoV-2 is key to preventing further spread but there is confusion over the meaning of “airborne” whenever transmission is discussed. Scientific ambivalence originates from evidence published many...

Jan 14 • Nature Medicine | 10 expert tweets ->
On the origins of SARS-CoV-2
Stakeholders in public health must lobby policy makers to make decisions based on evidence, not political expediency, particularly when the studies that hang in the balance are critical to understanding the origins of epidemics.

Jan 13 • The Atlantic | 10 expert tweets ->
The Atlantic Hires Katherine Wu as Staff Writer
Wu joins from The New York Times, and will cover the pandemic

Jan 13 • Nature Medicine | 9 expert tweets ->
Immune determinants of COVID-19 disease presentation and severity
The severity of COVID-19 varies by sex and age, and is linked to comorbidities. Differences in immune reactions may go some way to explain this.

Jan 14 • Science | 9 expert tweets ->
Herd immunity by infection is not an option
Herd immunity is expected to arise when a virus cannot spread readily, because it encounters a population that has a level of immunity that reduces the number of individuals susceptible to infection. On page 288 of this issue, Buss et al. ([ 1 ][1]) describe the extent of the largely uncontrolled severe acute respiratory syndrome coronavirus 2...

Jan 13 • The Atlantic | 8 expert tweets ->
Why Aren’t We Wearing Better Masks?
Cloth masks are better than nothing, but they were supposed to be a stopgap measure.

Jan 14 • Journal of Virology | 8 expert tweets ->
Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection
Identifying drugs that regulate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its symptoms has been a pressing area of investigation during the coronavirus disease 2019 (COVID-19) pandemic. Nonsteroidal anti-inflammatory drugs (NSAIDs), which are frequently used for the relief of pain and inflammation, could...

Jan 13 • Cell | 7 expert tweets ->
Messenger RNA vaccines against SARS-CoV-2
The first two vaccines proven to be effective for inhibiting COVID-19 illness were both mRNA, achieving 95% efficacy (and safety) among 74,000 participants (half receiving placebo) after intramuscular delivery of two shots, 3–4 weeks apart. To view this Bench to Bedside, open or download the PDF.

Johnson & Johnson Expects Vaccine Results Soon but Lags in Production
The U.S. needs J.&J.’s one-shot vaccine more than ever. But the company is behind on manufacturing promises made in its Operation Warp Speed contract.

Jan 13 • Global scientists double down on SARS | 6 expert tweets ->
Global scientists double down on SARS-CoV-2 variants research at WHO-hosted forum
Global scientists are intensifying research into COVID-19, as the World Health Organization (WHO) moves to expand its scientific collaboration and monitoring of emerging variants of SARS-CoV-2, the virus that causes COVID-19.

Jan 13 • New England Journal of Medicine | 6 expert tweets ->
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM
Original Article from The New England Journal of Medicine — Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Jan 13 • Opinion | 6 expert tweets ->
Opinion | The World Is Desperate for More Covid Vaccines
Two decades ago, the U.S. launched a program to help supply the world with H.I.V. medication. It should take a similar approach to Covid.

https://www.cell.com/med/pdf/S2666-6340(20)30072-6.pdf

COVID reinfections are unusual — but could still help the virus to spread
Large study of UK health-care workers suggests that most people are immune for months after catching COVID-19 for the first time.

Jan 14 • GOV.UK | 5 expert tweets ->
Past COVID-19 infection provides some immunity but people may still carry and transmit virus
Study finds past coronavirus (COVID-19) infection provides some immunity for at least 5 months, but people may still carry and transmit the virus.

https://www.usatoday.com/story/news/health/2021/01/13/moderna-covid-19-vaccine-trial-adolescent-volunteers-coronavirus/6646795002

https://www.sciencemag.org/news/2021/01/saliva-could-hold-clues-how-sick-you-will-get-covid-19

Jan 14 • Science | 5 expert tweets ->
Public debate is good for science
In the age of the internet, there's no such thing as a private debate. But is that bad for science? Some scientists have had misgivings. When debates in any sector move beyond the halls of universities and government agencies, there is potential for misuse of information and public confusion. But open debate can also foster communication among...

Next Page >
 
Page 1